<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02881268</url>
  </required_header>
  <id_info>
    <org_study_id>35RC15_9903_IMPRIM</org_study_id>
    <nct_id>NCT02881268</nct_id>
  </id_info>
  <brief_title>Study of Immunosuppression Biomarkers Acquired in Patients Hospitalized in Intensive Care Unit</brief_title>
  <acronym>IMPRIM</acronym>
  <official_title>Study of Immunosuppression Biomarkers Acquired in Patients Hospitalized in Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open-label, non-randomized, prospective, single center, observational, translational study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this trial is to study immunosuppression biomarkers in patients hospitalized in&#xD;
      intensive care unit in comparison to non-septic patients.&#xD;
&#xD;
      Prevalence of immunosuppression acquired in intensive care unit will be studied and patients&#xD;
      most likely to develop nosocomial infection will be early identified&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 19, 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of immunosuppression biomarkers in septic and non-septic patients hospitalized in intensive care unit</measure>
    <time_frame>Day 14</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association of immunosuppression biomarkers with occurrence of events reflecting a clinical immunosuppression</measure>
    <time_frame>Day 14</time_frame>
    <description>Study of CMV reactivation and nosocomial infections</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association of immunosuppression biomarkers with patients demographic data</measure>
    <time_frame>Day 14</time_frame>
    <description>Record of patient age and gender</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association of immunosuppression biomarkers with patients clinical data</measure>
    <time_frame>Day 14</time_frame>
    <description>Record of severity score, duration of hospitalization, duration of mechanical ventilation, morbidity</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Patient Hospitalized in Intensive Care Unit</condition>
  <arm_group>
    <arm_group_label>Patient with sepsis</arm_group_label>
    <description>Patient hospitalized in intensive care unit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient without sepsis</arm_group_label>
    <description>Patient hospitalized in intensive care unit</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <arm_group_label>Patient with sepsis</arm_group_label>
    <arm_group_label>Patient without sepsis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient hospitalized in intensive care unit with or without sepsis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient older than 18 years old&#xD;
&#xD;
          -  Patient hospitalized in intensive care unit for any reason&#xD;
&#xD;
          -  Patient with infection started less than 5 days before admission&#xD;
&#xD;
          -  Patient with mechanical ventilation or not&#xD;
&#xD;
          -  Patient with arterial catheter for an invasive monitoring of blood pressure&#xD;
&#xD;
          -  Patient informed about the study protocol and approved to participate.&#xD;
&#xD;
          -  Patients hospitalized for a severe bacterial infection (severe sepsis or septic shock)&#xD;
&#xD;
          -  Patient hospitalized for a non-infectious disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Advanced immunosuppression defined by proved humoral or cellular impairment by&#xD;
             continuous administration of steroids at any dose since more than one month before&#xD;
             hospitalization, transplantation, radiotherapy or chemotherapy in the preceding year&#xD;
&#xD;
          -  Initiation of an immunosuppressive therapy as chemotherapy, cyclophosphamide or high&#xD;
             dose corticotherapy (&gt;0.5mg/kg/day)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fabrice Uhel, MD</last_name>
    <phone>33 2 99 28 42 48</phone>
    <email>fabrice.uhel@chu-rennes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice Uhel, MD</last_name>
      <phone>+33 2 99 28 42 48</phone>
      <email>fabrice.uhel@chu-rennes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 18, 2016</study_first_submitted>
  <study_first_submitted_qc>August 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2016</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

